Sign Up to like & get
recommendations!
1
Published in 2022 at "Bioanalysis"
DOI: 10.4155/bio-2022-0004
Abstract: Background: Inhibition of the enzyme dipeptidyl peptidase 4 (DPP-4) is a pharmaceutical treatment for type 2 diabetes. To demonstrate bioequivalence of enzyme inhibition of a new dosage form of the inhibitor vildagliptin, a method for…
read more here.
Keywords:
inhibition dpp;
activity inhibition;
inhibition;
method ... See more keywords